Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Baihua Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and chemical drugs. The company's therapeutic focus spans several key areas, including gynecology, pediatrics, cardiovascular health, and respiratory medicine. Its commercial portfolio features well-known brands such as Fule Keli for gynecological inflammation and various pediatric digestive treatments. Headquartered in Guiyang, Guizhou Province, the firm operates advanced manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards. Guizhou Baihua Pharmaceutical integrates traditional herbal knowledge with modern pharmacological techniques to serve the domestic Chinese healthcare market. The company was previously listed on China's National Equities Exchange and Quotations, reflecting its established position in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Baihua Pharmaceutical.